Clinical trial
Randomised Crossover Comparison of the Ambu AuraGain and the iGel in Anaesthetised Adults
NCT02644837 is registered in ClinicalTrials.gov with NHS Tayside as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Crossover Comparison of the Ambu AuraGain and the iGel in Anaesthetised Adults
- Lead sponsor
- NHS Tayside
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 31, 2016
- Completion date
- August 31, 2017
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
airway management, laryngeal mask airway